comparemela.com

Latest Breaking News On - United kingdom based ergomed clinical research - Page 1 : comparemela.com

PharmAust latest report gives green light for continuing trials

PharmAust (ASX: PAA) has announced the company is adequately funded to continue its current activities after releasing its March quarter (Q3 FY22) report this week.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.